Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 6/20 | 0.35 |
| ▸ | USP2 | O75604 | 4/20 | 0.35 |
| ▸ | MAPT | P10636 | 4/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.35 |
| ▸ | HTT | P42858 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 2/20 | 0.32 |
| ▸ | PRKDC | P78527 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.30 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2984885 | 0.85 | LMNA (0.37) | LMNAUSP2MAPTKMT2AHTT | |
| SCHEMBL30990235 | 0.84 | LMNA (0.35) | LMNAUSP2MAPTKMT2AHTT | |
| SCHEMBL412859 | 0.78 | TSHR (0.38) | LMNAUSP2MAPTKMT2AHTT | |
| SCHEMBL12780188 | 0.74 | HTT (0.41) | LMNAUSP2MAPTKMT2AHTT | |
| SCHEMBL12764987 | 0.74 | PIK3R1 (0.37) | LMNAUSP2MAPTKMT2AHTT | |
| SCHEMBL5684441 | 0.72 | PIK3CD (0.37) | LMNAUSP2MAPTKMT2AHTT | |
| SCHEMBL14064636 | 0.70 | LGMN (0.45) | USP2MAPTKMT2AHTTMEN1 | |
| SCHEMBL8401943 | 0.70 | TSHR (0.37) | LMNAUSP2MAPTKMT2AHTT | |
| SCHEMBL17338970 | 0.70 | TSHR (0.41) | LMNAUSP2MAPTKMT2AHTT | |
| SCHEMBL791553 | 0.69 | MAPT (0.39) | LMNAUSP2MAPTKMT2AHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2459546-A1 | NEW BICYCLIC DIOXANES, THEIR PREPARATION AND THEIR USE AS FRAGRANT COMPOUNDS | V. Mane Fils (FR) | 2012-06-06 | — | — | EP | disclosed |
| EP-1979301-B1 | PERFUMING INGREDIENTS WITH ODOR OF THE PHEROMONE TYPE | FIRMENICH & CIE (CH) | 2012-03-14 | — | — | EP | disclosed |
| WO-2011013077-A1 | NEW BICYCLIC DIOXANES, THEIR PREPARATION AND THEIR USE AS FRAGRANT COMPOUNDS | V. MANE FILS (FR) | 2011-02-03 | — | — | WO | disclosed |
| US-7618934-B2 | Perfuming ingredients with odor of the pheromone type | FIRMENICH SA (CH) | 2009-11-17 | — | — | US | disclosed |
| US-20080280809-A1 | Perfuming Ingredients with Odor of the Pheromone Type | FIRMENICH SA, PPON | 2008-11-13 | — | — | US | disclosed |
| EP-1979301-A1 | PERFUMING INGREDIENTS WITH ODOR OF THE PHEROMONE TYPE | FIRMENICH SA (CH) | 2008-10-15 | — | — | EP | disclosed |
| WO-2007085984-A1 | PERFUMING INGREDIENTS WITH ODOR OF THE PHEROMONE TYPE | FIRMENICH SA (CH) | 2007-08-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080280809-A1 | Perfuming Ingredients with Odor of the Pheromone Type | DBN1, PTAR1, FDFT1 | LMNA 2787/4885USP2 3197/4885MAPT 1638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.